Literature DB >> 20864156

Characterization of the degradation mechanisms of lysine-derived aliphatic poly(ester urethane) scaffolds.

Andrea E Hafeman1, Katarzyna J Zienkiewicz, Angela L Zachman, Hak-Joon Sung, Lillian B Nanney, Jeffrey M Davidson, Scott A Guelcher.   

Abstract

Characterization of the degradation mechanism of polymeric scaffolds and delivery systems for regenerative medicine is essential to assess their clinical applicability. Key performance criteria include induction of a minimal, transient inflammatory response and controlled degradation to soluble non-cytotoxic breakdown products that are cleared from the body by physiological processes. Scaffolds fabricated from biodegradable poly(ester urethane)s (PEURs) undergo controlled degradation to non-cytotoxic breakdown products and support the ingrowth of new tissue in preclinical models of tissue regeneration. While previous studies have shown that PEUR scaffolds prepared from lysine-derived polyisocyanates degrade faster under in vivo compared to in vitro conditions, the degradation mechanism is not well understood. In this study, we have shown that PEUR scaffolds prepared from lysine triisocyanate (LTI) or a trimer of hexamethylene diisocyanate (HDIt) undergo hydrolytic, esterolytic, and oxidative degradation. Hydrolysis of ester bonds to yield α-hydroxy acids is the dominant mechanism in buffer, and esterolytic media modestly increase the degradation rate. While HDIt scaffolds show a modest (<20%) increase in degradation rate in oxidative medium, LTI scaffolds degrade six times faster in oxidative medium. Furthermore, the in vitro rate of degradation of LTI scaffolds in oxidative medium approximates the in vivo rate in rat excisional wounds, and histological sections show macrophages expressing myeloperoxidase at the material surface. While recent preclinical studies have underscored the potential of injectable PEUR scaffolds and delivery systems for tissue regeneration, this promising class of biomaterials has a limited regulatory history. Elucidation of the macrophage-mediated oxidative mechanism by which LTI scaffolds degrade in vivo provides key insights into the ultimate fate of these materials when injected into the body.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20864156      PMCID: PMC2997347          DOI: 10.1016/j.biomaterials.2010.08.108

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  49 in total

1.  Foreign-body giant cells and polyurethane biostability: in vivo correlation of cell adhesion and surface cracking.

Authors:  Q Zhao; N Topham; J M Anderson; A Hiltner; G Lodoen; C R Payet
Journal:  J Biomed Mater Res       Date:  1991-02

2.  Synthesis, characterization and cytocompatibility of polyurethaneurea elastomers with designed elastase sensitivity.

Authors:  Jianjun Guan; William R Wagner
Journal:  Biomacromolecules       Date:  2005 Sep-Oct       Impact factor: 6.988

3.  In vitro degradation of a poly(propylene fumarate)-based composite material.

Authors:  M J Yaszemski; R G Payne; W C Hayes; R Langer; A G Mikos
Journal:  Biomaterials       Date:  1996-11       Impact factor: 12.479

4.  Biodegradable porous polyurethane scaffolds for tissue repair and regeneration.

Authors:  Katarzyna Gorna; Sylwester Gogolewski
Journal:  J Biomed Mater Res A       Date:  2006-10       Impact factor: 4.396

5.  Synthesis and in vitro biocompatibility of injectable polyurethane foam scaffolds.

Authors:  Scott A Guelcher; Vishal Patel; Katie M Gallagher; Susan Connolly; Jonathan E Didier; John S Doctor; Jeffrey O Hollinger
Journal:  Tissue Eng       Date:  2006-05

6.  Regeneration of bicortical defects in the iliac crest of estrogen-deficient sheep, using new biodegradable polyurethane bone graft substitutes.

Authors:  Sylwester Gogolewski; Katarzyna Gorna; A Simon Turner
Journal:  J Biomed Mater Res A       Date:  2006-06-15       Impact factor: 4.396

7.  Synthesis, biodegradability, and biocompatibility of lysine diisocyanate-glucose polymers.

Authors:  Jian-Ying Zhang; Eric J Beckman; Jing Hu; Guo-Guang Yang; Sudha Agarwal; Jeffrey O Hollinger
Journal:  Tissue Eng       Date:  2002-10

8.  Preparation and characterization of highly porous, biodegradable polyurethane scaffolds for soft tissue applications.

Authors:  Jianjun Guan; Kazuro L Fujimoto; Michael S Sacks; William R Wagner
Journal:  Biomaterials       Date:  2005-06       Impact factor: 12.479

9.  TNF-alpha and IL-1 beta upregulate nitric oxide-dependent ciliary motility in bovine airway epithelium.

Authors:  B Jain; I Rubinstein; R A Robbins; J H Sisson
Journal:  Am J Physiol       Date:  1995-06

10.  Synthetic polymeric substrates as potent pro-oxidant versus anti-oxidant regulators of cytoskeletal remodeling and cell apoptosis.

Authors:  Hak-Joon Sung; Prafulla Chandra; Matthew D Treiser; Er Liu; Carmine P Iovine; Prabhas V Moghe; Joachim Kohn
Journal:  J Cell Physiol       Date:  2009-03       Impact factor: 6.384

View more
  33 in total

1.  Degradable segmented polyurethane elastomers for bone tissue engineering: effect of polycaprolactone content.

Authors:  Katherine D Kavlock; Kyumin Whang; Scott A Guelcher; Aaron S Goldstein
Journal:  J Biomater Sci Polym Ed       Date:  2012-05-11       Impact factor: 3.517

2.  Poly(Thioketal Urethane) Autograft Extenders in an Intertransverse Process Model of Bone Formation.

Authors:  Madison A P McGough; Stefanie M Shiels; Lauren A Boller; Katarzyna J Zienkiewicz; Craig L Duvall; Joseph C Wenke; Scott A Guelcher
Journal:  Tissue Eng Part A       Date:  2019-01-09       Impact factor: 3.845

3.  Sustained local delivery of siRNA from an injectable scaffold.

Authors:  Christopher E Nelson; Mukesh K Gupta; Elizabeth J Adolph; Joshua M Shannon; Scott A Guelcher; Craig L Duvall
Journal:  Biomaterials       Date:  2011-11-05       Impact factor: 12.479

4.  A transient cell-shielding method for viable MSC delivery within hydrophobic scaffolds polymerized in situ.

Authors:  Ruijing Guo; Catherine L Ward; Jeffrey M Davidson; Craig L Duvall; Joseph C Wenke; Scott A Guelcher
Journal:  Biomaterials       Date:  2015-03-27       Impact factor: 12.479

Review 5.  Injectable foams for regenerative medicine.

Authors:  Edna M Prieto; Jonathan M Page; Andrew J Harmata; Scott A Guelcher
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2013-10-11

6.  Oxidatively Degradable Poly(thioketal urethane)/Ceramic Composite Bone Cements with Bone-Like Strength.

Authors:  Madison A P McEnery; Sichang Lu; Mukesh K Gupta; Katarzyna J Zienkiewicz; Joseph C Wenke; Kerem N Kalpakci; Daniel Shimko; Craig L Duvall; Scott A Guelcher
Journal:  RSC Adv       Date:  2016-11-08       Impact factor: 3.361

7.  Tunable delivery of siRNA from a biodegradable scaffold to promote angiogenesis in vivo.

Authors:  Christopher E Nelson; Arnold J Kim; Elizabeth J Adolph; Mukesh K Gupta; Fang Yu; Kyle M Hocking; Jeffrey M Davidson; Scott A Guelcher; Craig L Duvall
Journal:  Adv Mater       Date:  2013-12-16       Impact factor: 30.849

8.  Injectable polyurethane composite scaffolds delay wound contraction and support cellular infiltration and remodeling in rat excisional wounds.

Authors:  Elizabeth J Adolph; Andrea E Hafeman; Jeffrey M Davidson; Lillian B Nanney; Scott A Guelcher
Journal:  J Biomed Mater Res A       Date:  2011-11-21       Impact factor: 4.396

9.  Nanocrystalline hydroxyapatite-poly(thioketal urethane) nanocomposites stimulate a combined intramembranous and endochondral ossification response in rabbits.

Authors:  Madison A P McGough; Lauren A Boller; Dustin M Groff; Jonathan G Schoenecker; Jeffry S Nyman; Joseph C Wenke; Cheyenne Rhodes; Dan Shimko; Craig L Duvall; Scott A Guelcher
Journal:  ACS Biomater Sci Eng       Date:  2019-12-10

10.  Characterization and biocompatibility studies of new degradable poly(urea)urethanes prepared with arginine, glycine or aspartic acid as chain extenders.

Authors:  L H Chan-Chan; C Tkaczyk; R F Vargas-Coronado; J M Cervantes-Uc; M Tabrizian; J V Cauich-Rodriguez
Journal:  J Mater Sci Mater Med       Date:  2013-04-25       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.